A Study of Daridorexant in Chinese Patients With Insomnia Disorder

PHASE3CompletedINTERVENTIONAL
Enrollment

206

Participants

Timeline

Start Date

August 28, 2023

Primary Completion Date

April 12, 2024

Study Completion Date

May 10, 2024

Conditions
Insomnia Disorder
Interventions
DRUG

Daridorexant

Participants will receive one Daridorexant 50mg tablet, orally, once daily for about 28 consecutive night on each night approximately 30mintues before participants intends to try to sleep.

DRUG

Placebo

Participants will receive one placebo matched to daridorexant 50 mg tablet , orally, once daily for about 28 consecutive nights on each night approximately 30mintues before participants intends to try to sleep.

Trial Locations (33)

100053

Xuanwu Hospital of Capital Medical University, Beijing

Unknown

The Second People's Hospital Of Hefei, Hefei

Beijing Huilongguan Hospital, Beijing

Peking University Sixth Hospital, Beijing

Chengdu Second People's Hospital, Chengdu

Chongqing Traditional Chinese Medicine Hospital, Chongqing

The First Affiliated Hospital of Fujian Medical University, Fuzhou

Guangdong Provincial People's Hospital, Guangzhou

Nanfang Hospital, Guangzhou

The First Affiliated Hospital of Jinan University, Guangzhou

Hainan General Hospital, Haikou

The First Hospital of Hebei Medical University, Shijiazhuang

The Third Hospital of Hebei Medical University, Shijiazhuang

The First Affiliated Hospital of Henan University of Science and Technology, Luoyang

Xiangya Hospital of Central South University, Changsha

Nanjing Brain Hospital, Nanjing

The Second Hospital of Suzhou University, Suzhou

The Second Affiliated Hospital of Nanchang University, Nanchang

The First Hospital of Jilin University, Changchun

The Second Affiliated Hospital of Dalian Medical University, Dalian

Shengjing Hospital of China Medical University, Shenyang

The First Affiliated Hospital of Shandong First Medical University (Shandong Provincial Qianfoshan Hospital), Jinan

The Affiliated Hospital of Qingdao University, Qingdao

Tai'an Central Hospital, Tai’an

Huashan Hospital Fudan University, Shanghai

Shanghai Mental Health Center, Shanghai

The First Hospital of Shanxi Medical University, Taiyuan

The Second Hospital of Shanxi Medical University, Taiyuan

Xianyang Hospital of Yan'an University, Xianyang

Deyang People's Hospital, Deyang

Tianjin Mental Health Center, Tianjin

Tianjin People's Hospital, Tianjin

Hangzhou Seventh People's Hospital, Hangzhou

All Listed Sponsors
lead

Jiangsu Simcere Pharmaceutical Co., Ltd.

INDUSTRY